Intended only for researchers
raw data set of Raman spectra
January 20, 2022
Noisy rainbow has a story to tell >
Lata Jayaraman, head of Oncology Drug Discovery
January 20, 2022
Catching a Tumor: Highlighting Bristol Myers Squibb’s commitment to facing the challenge of cancer resistance >
A hands-on STEM activity led by Bristol Myers Squibb volunteers
December 14, 2021
Opening doors to STEM for the next generation >
December 08, 2021
The potential of our pipeline >
CD47 embedded in the cell membrane
December 07, 2021
Pulling back the curtain on CD47 >
CAR T cell therapy in action
December 07, 2021
‘Serial killer’ CAR T cells target and destroy tumor cells in Bristol Myers Squibb lab >
November 11, 2021
It’s not all smiles in drug development >
Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb
November 10, 2021
The future of cancer care: transformative innovation for all >
David Gordon, Ph.D., vice president, Cardiovascular and Fibrosis Discovery Biology
November 10, 2021
Pioneering innovation in cardiovascular diseases >
Tumor Microenvironment research
November 01, 2021
Insights from research into the complexities of the Tumor Microenvironment (TME) >
Mixed race healthcare professionals
October 28, 2021
Experts weigh in: immunotherapy in earlier stages of cancer >
October 24, 2021
Uncovering the next wave of cancer treatments >